Bellevue Group’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-31,800
| Closed | -$150K | – | 223 |
|
|
2021
Q1 | $150K | Sell |
31,800
-2,680,283
| -99% | -$12.6M | ﹤0.01% | 216 |
|
|
2020
Q4 | $19.4M | Hold |
2,712,083
| – | – | 0.22% | 102 |
|
|
2020
Q3 | $28.9M | Hold |
2,712,083
| – | – | 0.4% | 69 |
|
|
2020
Q2 | $34.2M | Sell |
2,712,083
-12,000
| -0.4% | -$151K | 0.48% | 53 |
|
|
2020
Q1 | $24.9M | Buy |
2,724,083
+19,800
| +0.7% | +$181K | 0.48% | 54 |
|
|
2019
Q4 | $37.7M | Sell |
2,704,283
-400
| -0% | -$5.58K | 0.6% | 44 |
|
|
2019
Q3 | $46.5M | Buy |
2,704,683
+24,400
| +0.9% | +$420K | 0.87% | 35 |
|
|
2019
Q2 | $73M | Buy |
+2,680,283
| New | +$73M | 1.25% | 24 |
|
|
2019
Q1 | – | Sell |
-27,900
| Closed | -$262K | – | 148 |
|
|
2018
Q4 | $262K | Sell |
27,900
-15,522
| -36% | -$146K | 0.02% | 135 |
|
|
2018
Q3 | $822K | Buy |
43,422
+26,500
| +157% | +$502K | 0.05% | 129 |
|
|
2018
Q2 | $331K | Buy |
+16,922
| New | +$331K | 0.03% | 137 |
|